CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands	Total	Common Shares	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Class A Redeemable Convertible Preferred Shares	Class B Redeemable Convertible Preferred Shares	Class C Redeemable Convertible Preferred Shares
Beginning balance (in shares) at Oct. 31, 2022						266,696	156,036	5,560,607
Beginning balance at Oct. 31, 2022						$ 1,899	$ 1,554	$ 49,665
Beginning balance (in shares) at Oct. 31, 2022		665,767
Beginning balance at Oct. 31, 2022	$ (76,614)	$ 16,390	$ 7,683	$ (1,016)	$ (99,671)
Exercise of stock options (in shares)		1,804
Exercise of stock options		$ 6	(6)
Share-based compensation expense	20		20
Net Income (Loss)	(7,418)				(7,418)
Ending balance (in shares) at Jan. 31, 2023						266,696	156,036	5,560,607
Ending balance at Jan. 31, 2023						$ 1,899	$ 1,554	$ 49,665
Ending balance (in shares) at Jan. 31, 2023		667,571
Ending balance at Jan. 31, 2023	(84,012)	$ 16,396	7,697	(1,016)	(107,089)
Beginning balance (in shares) at Oct. 31, 2022						266,696	156,036	5,560,607
Beginning balance at Oct. 31, 2022						$ 1,899	$ 1,554	$ 49,665
Beginning balance (in shares) at Oct. 31, 2022		665,767
Beginning balance at Oct. 31, 2022	(76,614)	$ 16,390	7,683	(1,016)	(99,671)
Net Income (Loss)	(12,700)
Ending balance (in shares) at Apr. 30, 2023						266,696	156,036	5,560,607
Ending balance at Apr. 30, 2023						$ 1,899	$ 1,554	$ 49,665
Ending balance (in shares) at Apr. 30, 2023		701,323
Ending balance at Apr. 30, 2023	(89,238)	$ 16,434	7,715	(1,016)	(112,371)
Beginning balance (in shares) at Oct. 31, 2022						266,696	156,036	5,560,607
Beginning balance at Oct. 31, 2022						$ 1,899	$ 1,554	$ 49,665
Beginning balance (in shares) at Oct. 31, 2022		665,767
Beginning balance at Oct. 31, 2022	(76,614)	$ 16,390	7,683	(1,016)	(99,671)
Ending balance (in shares) at Oct. 31, 2023		23,197,976
Ending balance at Oct. 31, 2023	72,486	$ 259,373	13,717	(1,016)	(199,588)
Beginning balance (in shares) at Jan. 31, 2023						266,696	156,036	5,560,607
Beginning balance at Jan. 31, 2023						$ 1,899	$ 1,554	$ 49,665
Beginning balance (in shares) at Jan. 31, 2023		667,571
Beginning balance at Jan. 31, 2023	(84,012)	$ 16,396	7,697	(1,016)	(107,089)
Exercise of stock options (in shares)		18,258
Exercise of stock options	17	$ 27	(10)
Issuance of common shares upon cashless exercise of options (in shares)		15,494
Issuance of common shares upon cashless exercise of options		$ 11	(11)
Share-based compensation expense	39		39
Net Income (Loss)	(5,282)				(5,282)
Ending balance (in shares) at Apr. 30, 2023						266,696	156,036	5,560,607
Ending balance at Apr. 30, 2023						$ 1,899	$ 1,554	$ 49,665
Ending balance (in shares) at Apr. 30, 2023		701,323
Ending balance at Apr. 30, 2023	(89,238)	$ 16,434	7,715	(1,016)	(112,371)
Beginning balance (in shares) at Oct. 31, 2023		23,197,976
Beginning balance at Oct. 31, 2023	72,486	$ 259,373	13,717	(1,016)	(199,588)
Share-based compensation expense	291		291
Issuance of warrants in connection with Amended Term Loan	319		319
Net Income (Loss)	(10,711)				(10,711)
Ending balance (in shares) at Jan. 31, 2024		23,197,976
Ending balance at Jan. 31, 2024	62,385	$ 259,373	14,327	(1,016)	(210,299)
Beginning balance (in shares) at Oct. 31, 2023		23,197,976
Beginning balance at Oct. 31, 2023	$ 72,486	$ 259,373	13,717	(1,016)	(199,588)
Exercise of stock options (in shares)	56,974
Net Income (Loss)	$ (25,695)
Ending balance (in shares) at Apr. 30, 2024		44,158,587
Ending balance at Apr. 30, 2024	242,966	$ 453,405	15,860	(1,016)	(225,283)
Beginning balance (in shares) at Jan. 31, 2024		23,197,976
Beginning balance at Jan. 31, 2024	62,385	$ 259,373	14,327	(1,016)	(210,299)
Exercise of stock options (in shares)		56,974
Exercise of stock options	51	$ 207	(156)
Share-based compensation expense	1,917		1,917
Issuance of common shares in connection with PIPE Financing, net of issuance costs (in shares)		20,000,000
Issuance of common shares in connection with PIPE Financing, net of issuance costs	187,614	$ 187,614
Issuance of common shares upon exercise of warrants (in shares)		520,282
Issuance of common shares upon exercise of warrants	5,983	$ 6,114	(131)
Issuance of common shares upon cashless exercise of warrants (in shares)		383,355
Issuance of common shares upon cashless exercise of warrants		$ 97	(97)
Net Income (Loss)	(14,984)				(14,984)
Ending balance (in shares) at Apr. 30, 2024		44,158,587
Ending balance at Apr. 30, 2024	$ 242,966	$ 453,405	$ 15,860	$ (1,016)	$ (225,283)